TY - JOUR
T1 - Risk of infectious mononucleosis is not associated with prior infection morbidity
AU - Rostgaard, Klaus
AU - Kristjánsson, Ragnar
AU - Davidsson, Olafur
AU - Biel-Nielsen Dietz, Jojo
AU - Søegaard, Signe Holst
AU - Stensballe, Lone Graff
AU - Hjalgrim, Henrik
N1 - Publisher Copyright:
2025 Rostgaard, Kristjánsson, Davidsson, Biel-Nielsen Dietz, Søegaard, Stensballe and Hjalgrim.
PY - 2025
Y1 - 2025
N2 - Background: The probability of presenting with infectious mononucleosis (IM) upon primary Epstein–Barr virus infection increases dramatically at the start of puberty. Aiming to understand why that is, we assessed whether the number of infection-related health events during two specific time periods−ages 10–12 years (pre-teen window) and the three most recent years (recent window)−could predict the likelihood of individuals aged 13–19 years developing IM. Methods: We used sibship-stratified Cox regression to mitigate socio-demographic confounding and bias. Consequently, we only followed members of IM-affected sibships aged 13–19 years between 1999 and 2021 for IM, based on information from complete nationwide Danish administrative and health registers. Estimates were further adjusted for sex, age, birth order (1, 2, 3+) and sibship constellation [number of siblings and their signed (older/younger) age difference to the index person]. Infection-related health events defining the exposures considered were either a category of antimicrobial prescription, or a hospital contact with an infectious disease diagnosis. We measured evidence/probability of the associations using asymptotic Bayes factors, rather than using p-value based testing. Results: The adjusted hazard ratio (HR) for IM with 95% confidence limits for an additional antimicrobial prescription in the pre-teen exposure window was [1.01; 0.98–1.04], and the corresponding adjusted HR for an additional antimicrobial prescription in the recent exposure window was [1.02; 0.99–1.06]. Conclusions: IM was not preceded by unusual numbers of infections. Small effect sizes, together with small variation in exposure, did not render the assessed exposures useful for predicting IM for public health or the clinic.
AB - Background: The probability of presenting with infectious mononucleosis (IM) upon primary Epstein–Barr virus infection increases dramatically at the start of puberty. Aiming to understand why that is, we assessed whether the number of infection-related health events during two specific time periods−ages 10–12 years (pre-teen window) and the three most recent years (recent window)−could predict the likelihood of individuals aged 13–19 years developing IM. Methods: We used sibship-stratified Cox regression to mitigate socio-demographic confounding and bias. Consequently, we only followed members of IM-affected sibships aged 13–19 years between 1999 and 2021 for IM, based on information from complete nationwide Danish administrative and health registers. Estimates were further adjusted for sex, age, birth order (1, 2, 3+) and sibship constellation [number of siblings and their signed (older/younger) age difference to the index person]. Infection-related health events defining the exposures considered were either a category of antimicrobial prescription, or a hospital contact with an infectious disease diagnosis. We measured evidence/probability of the associations using asymptotic Bayes factors, rather than using p-value based testing. Results: The adjusted hazard ratio (HR) for IM with 95% confidence limits for an additional antimicrobial prescription in the pre-teen exposure window was [1.01; 0.98–1.04], and the corresponding adjusted HR for an additional antimicrobial prescription in the recent exposure window was [1.02; 0.99–1.06]. Conclusions: IM was not preceded by unusual numbers of infections. Small effect sizes, together with small variation in exposure, did not render the assessed exposures useful for predicting IM for public health or the clinic.
KW - Bayes factor
KW - Epstein–Barr Virus
KW - immune system
KW - infections
KW - infectious mononucleosis
KW - puberty
U2 - 10.3389/fepid.2025.1518559
DO - 10.3389/fepid.2025.1518559
M3 - Journal article
C2 - 40144892
AN - SCOPUS:105001288829
SN - 2674-1199
VL - 5
JO - Frontiers in Epidemiology
JF - Frontiers in Epidemiology
M1 - 1518559
ER -